Risk Factors for Clostridium Difficile Diarrhea in Patients With Solid Organ Transplantation. (September 2016)

• Record Type: Journal Article
• Authors: Ramos, Antonio; Ortiz, Jorge; Asensio, Ángel; Martínez-Ruiz, Rocío; Múñez, Elena; Cantero, Mireia; Cozar, Alberto; Ussetti, Piedad; Portolés, José; Cuervas-Mons, Valentín
• Is Part Of: Progress in transplantation. Volume 26:Number 3(2016)
• Page Start: 231
• Page End: 237
• Publication Date: 2016-09
• Subjects: Clostridium difficile -- antibiotic-associated diarrhea -- metronidazole -- proton pump inhibitors -- mycophenolate mofetil; Transplantation of organs, tissues, etc -- Periodicals; Transplantation; Organ Procurement; Tissue Donors; Transplantation of organs, tissues, etc; Electronic journals; Periodicals; Periodicals; 362.1783
• DOI: 10.1177/1526924816655073
• Languages: English
• ISSNs: 1526-9248

Abstract

Background: There is limited knowledge about specific risk factors for Clostridium difficile infection (CDI). Method: A retrospective study comparing cases of CDI in solid organ transplant (SOT) recipients with controls (SOT recipients who did not present CDI). Results: Thirty patients with SOT from 1340 transplantation recipients had at least 1 episode of CDI (2.23%). The accumulated incidence was 3.06% in liver transplantation, 2.78% in lung transplantation, 2.36% in kidney transplantation, and 0.33% in heart transplantation. Seven (23%) cases occurred during the first 2 months. Fifteen (50%) cases were community acquired. Colonoscopy was performed in 6 (20%) cases, but pseudomembranes were observed in only 1 (16%) case. Independent variables found to be related to CDI were previous treatment with proton pump inhibitors (PPIs; odds ratio [OR] 5.5; 95% confidence interval [CI] 1.2-32.0), immunosuppressive regimen including mycophenolate (OR 5.2; 95%CI 1.1-18), hospitalization during the previous 3 months (OR 5.1; 95%CI 1.1-17), and antibiotic treatment during the previous month (OR 6.7; 95%CI 1.4-23). Five (16.7%) patients did not respond to the initial treatment. Recurrences were noted in 6 (20%) patients. Conclusions: Liver transplant recipients presented the highest incidence. Risk factors for CDI were previous treatment with PPIs, immunosuppressive regimen containing mycophenolate, prior hospitalization, and prior antibiotic treatment.